Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?

Walker AJ, Ruzevick J, Malayeri AA, Rigamonti D, Lim M, Redmond KJ, Kleinberg L.

Future Oncol. 2014 May;10(7):1277-97. doi: 10.2217/fon.13.271. Review.

2.
3.

Stereotactic radiosurgery. VIII. The classification of postradiation reactions.

Plowman PN.

Br J Neurosurg. 1999 Jun;13(3):256-64.

PMID:
10562835
4.

Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practice.

Ruzevick J, Kleinberg L, Rigamonti D.

Neurosurg Rev. 2014 Apr;37(2):193-201; discussion 201. doi: 10.1007/s10143-013-0504-8. Epub 2013 Nov 15. Review.

5.

Pseudoprogression: relevance with respect to treatment of high-grade gliomas.

Fink J, Born D, Chamberlain MC.

Curr Treat Options Oncol. 2011 Sep;12(3):240-52. doi: 10.1007/s11864-011-0157-1. Review.

PMID:
21594589
6.

Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?

Belohlávek O, Simonová G, Kantorová I, Novotný J Jr, Liscák R.

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):96-100. Epub 2002 Nov 5.

PMID:
12483415
7.

Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.

Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D, Richey K, Park S, Pieper DR, Chen PY, Grills IS.

Magn Reson Imaging. 2011 Sep;29(7):993-1001. doi: 10.1016/j.mri.2011.04.004. Epub 2011 May 14.

PMID:
21571478
8.
9.

T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.

Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD.

Neurosurgery. 2010 Mar;66(3):486-91; discussion 491-2. doi: 10.1227/01.NEU.0000360391.35749.A5.

PMID:
20173543
10.

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

Shah AH, Snelling B, Bregy A, Patel PR, Tememe D, Bhatia R, Sklar E, Komotar RJ.

J Neurooncol. 2013 Apr;112(2):141-52. doi: 10.1007/s11060-013-1059-9. Epub 2013 Jan 24. Review.

PMID:
23344789
11.

Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.

Kickingereder P, Dorn F, Blau T, Schmidt M, Kocher M, Galldiks N, Ruge MI.

Radiat Oncol. 2013 Mar 6;8:52. doi: 10.1186/1748-717X-8-52. Review.

12.

Stereotactic biopsy combined with stereotactic (125)iodine brachytherapy for diagnosis and treatment of locally recurrent single brain metastases.

Ruge MI, Kickingereder P, Grau S, Hoevels M, Treuer H, Sturm V.

J Neurooncol. 2011 Oct;105(1):109-18. doi: 10.1007/s11060-011-0571-z. Epub 2011 Apr 11.

PMID:
21479963
13.

[Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].

Patsouris A, Augereau P, Tanguy JY, Morel O, Menei P, Rousseau A, Paumier A.

Cancer Radiother. 2014 Mar;18(2):142-6. doi: 10.1016/j.canrad.2013.10.013. Epub 2014 Jan 13. French.

PMID:
24433952
14.

Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.

Leeman JE, Clump DA, Flickinger JC, Mintz AH, Burton SA, Heron DE.

Neuro Oncol. 2013 Dec;15(12):1732-8. doi: 10.1093/neuonc/not130.

15.

Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery.

Torres-Reveron J, Tomasiewicz HC, Shetty A, Amankulor NM, Chiang VL.

J Neurooncol. 2013 Jul;113(3):495-503. doi: 10.1007/s11060-013-1142-2. Epub 2013 May 16.

PMID:
23677747
16.

Post-treatment imaging changes in primary brain tumors.

O'Brien BJ, Colen RR.

Curr Oncol Rep. 2014;16(8):397. doi: 10.1007/s11912-014-0397-x. Review.

PMID:
24997979
17.

Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma.

Bakardjiev AI, Barnes PD, Goumnerova LC, Black PM, Scott RM, Pomeroy SL, Billett A, Loeffler JS, Tarbell NJ.

Cancer. 1996 Aug 15;78(4):864-73.

18.

Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.

Choi YJ, Kim HS, Jahng GH, Kim SJ, Suh DC.

Acta Radiol. 2013 May;54(4):448-54. doi: 10.1177/0284185112474916. Epub 2013 Apr 30.

PMID:
23592805
19.

Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.

Huber PE, Hawighorst H, Fuss M, van Kaick G, Wannenmacher MF, Debus J.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1339-49.

PMID:
11286842
20.

Imaging after GliaSite brachytherapy: prognostic MRI indicators of disease control and recurrence.

Kleinberg L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1385-91. doi: 10.1016/j.ijrobp.2008.12.074. Epub 2009 Apr 23.

PMID:
19394153
Items per page

Supplemental Content

Write to the Help Desk